AR109248A1 - Procedimiento para la preparación de 4-fenilbutirato y sus usos - Google Patents

Procedimiento para la preparación de 4-fenilbutirato y sus usos

Info

Publication number
AR109248A1
AR109248A1 ARP170101424A ARP170101424A AR109248A1 AR 109248 A1 AR109248 A1 AR 109248A1 AR P170101424 A ARP170101424 A AR P170101424A AR P170101424 A ARP170101424 A AR P170101424A AR 109248 A1 AR109248 A1 AR 109248A1
Authority
AR
Argentina
Prior art keywords
phenyl
butyric acid
procedure
preparation
triphenylbutyrate
Prior art date
Application number
ARP170101424A
Other languages
English (en)
Inventor
Andrew Thompson
Steven Weissman
Maki Uragami
Vasilios H Iskos
Steven S Pfeiffer
Huai-Chueh Chang
Original Assignee
Horizon Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horizon Therapeutics Llc filed Critical Horizon Therapeutics Llc
Publication of AR109248A1 publication Critical patent/AR109248A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/616—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
    • C07C51/29—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation with halogen-containing compounds which may be formed in situ
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/58—Preparation of carboxylic acid halides
    • C07C51/60—Preparation of carboxylic acid halides by conversion of carboxylic acids or their anhydrides or esters, lactones, salts into halides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/14—Preparation of carboxylic acid esters from carboxylic acid halides

Abstract

Un procedimiento para preparar ácido 4-fenil-1-butírico, que comprende: hacer reaccionar 4-fenil-1-butanol con clorito sódico, un catalizador del radical nitroxilo e hipoclorito sódico en un disolvente orgánico y un amortiguador de fosfato; y paralizar la reacción con sulfito sódico para producir 4-fenil-1-butírico. También ácido 4-fenil-1-butírico preparado mediante tal procedimiento. Preparación de trifenilbutirato de glicerilo y su uso en el tratamiento de un trastorno del ciclo de la urea. Reivindicación 25: Un procedimiento para preparar trifenilbutirato de glicerol, caracterizado porque comprende: convertir ácido 4-fenil-1-butírico de la reivindicación 21, en cloruro de 4-fenil-1-butirilo; y hacer reaccionar el cloruro de 4-fenil-1-butirilo con glicerol en un disolvente orgánico en presencia de una base adecuada.
ARP170101424A 2016-05-25 2017-05-24 Procedimiento para la preparación de 4-fenilbutirato y sus usos AR109248A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/164,126 US9914692B2 (en) 2016-05-25 2016-05-25 Procedure for the preparation of 4-phenyl butyrate and uses thereof

Publications (1)

Publication Number Publication Date
AR109248A1 true AR109248A1 (es) 2018-11-14

Family

ID=60412929

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170101424A AR109248A1 (es) 2016-05-25 2017-05-24 Procedimiento para la preparación de 4-fenilbutirato y sus usos

Country Status (4)

Country Link
US (3) US9914692B2 (es)
AR (1) AR109248A1 (es)
TW (1) TW201741278A (es)
WO (1) WO2017205515A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3263102A1 (en) 2011-09-30 2018-01-03 Horizon Therapeutics, LLC Methods of therapeutic monitoring of nitrogen scavenging drugs
US9914692B2 (en) 2016-05-25 2018-03-13 Horizon Therapeutics, Llc Procedure for the preparation of 4-phenyl butyrate and uses thereof
US10668040B2 (en) 2017-09-11 2020-06-02 Horizon Therapeutics, Llc Treatment of urea cycle disorders in neonates and infants
CN108530290A (zh) * 2018-06-04 2018-09-14 福州华博立乐新材料科技有限公司 一种4-苯基-1-丁酸的合成方法
CN113845420B (zh) * 2021-10-22 2024-04-16 安徽沃泰生物医药有限公司 苯丁酸甘油酯的合成工艺

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3686238A (en) 1970-01-19 1972-08-22 Syntex Corp Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
US4284647A (en) 1980-03-31 1981-08-18 The Johns Hopkins University Process for waste nitrogen removal
US4457942A (en) 1982-08-20 1984-07-03 Brusilow Saul W Process for waste nitrogen removal
US5635532A (en) 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US5879657A (en) 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
ES2157422T3 (es) 1995-02-07 2001-08-16 Brusilow Entpr Llc Trigliceridos y esteres etilicos de acido fenilalcanoico y acido fenilalquenoico utiles en el tratamiento de diversos trastornos.
US6219567B1 (en) 1999-06-21 2001-04-17 Cardiox Corporation Monitoring of total ammoniacal concentration in blood
IT1317073B1 (it) 2000-12-12 2003-05-26 Mini Ricerca Scient Tecnolog Esteri dell'acido fenilbutirrico, procedimenti per la loro produzionee loro impiego terapeutico.
US6372938B1 (en) * 2001-05-21 2002-04-16 Stanislaw R. Burzynski Synthesis of 4-phenylbutyric acid
US20030195255A1 (en) 2002-04-12 2003-10-16 Summar Marshall L. Method for treating hepatic encephalopathies
US20040229948A1 (en) 2002-04-12 2004-11-18 Summar Marshall L. Method for preventing hepatic encephalopathic episodes
US6825384B1 (en) 2004-01-29 2004-11-30 The Nutrasweet Company Bromine free TEMPO based catalyst system for oxidation of primary and secondary alcohols using NaOCl as an oxidant
US20050273359A1 (en) 2004-06-03 2005-12-08 Young David E System and method of evaluating preoperative medical care and determining recommended tests based on patient health history and medical condition and nature of surgical procedure
CN1778963A (zh) 2004-11-23 2006-05-31 苏州艾杰生物科技有限公司 血氨含量测定方法及血氨诊断试剂盒
KR101380446B1 (ko) 2004-11-26 2014-04-01 유씨엘 비즈니스 피엘씨 오르니틴 및 페닐아세테이트 또는 페닐부티레이트를 포함한간성 뇌병증 치료용 조성물
US20060135612A1 (en) 2004-12-17 2006-06-22 U.S. Department Of Veterans Affairs Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), by using a HDAC inhibiting agent
US20070004805A1 (en) 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
US20100016207A1 (en) 2005-11-10 2010-01-21 Wurtman Richard J Methods and Compositions for Raising Levels and Release of Gamma Aminobutyric Acid
CN101096363B (zh) * 2006-06-27 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途
US8094521B2 (en) 2007-02-28 2012-01-10 Nightingale Products LLC Caregiver personal alert device
CA2711807A1 (en) 2008-01-08 2009-07-16 Akthelia Pharmaceuticals Agonists for antimicrobial peptide systems
PL3133396T3 (pl) 2008-04-29 2019-03-29 Horizon Therapeutics, Llc Sposób leczenia z zastosowaniem leków wychwytujących amoniak
WO2009145323A1 (ja) * 2008-05-30 2009-12-03 日産化学工業株式会社 多環式化合物を用いるアルコールの酸化方法
WO2010025303A1 (en) 2008-08-29 2010-03-04 Hyperion Therapeutics Dosing and monitoring patients on nitrogen-scavenging drugs
LT3133396T (lt) 2008-08-29 2018-11-26 Horizon Therapeutics, Llc Gydymo būdai, panaudojant amoniaką deaktyvuojančius vaistus
PT2456304E (pt) 2009-07-24 2015-10-12 Baylor College Medicine Métodos de modulação de ácidos de cadeia ramificada e utilização dos mesmos
US8871981B2 (en) 2010-07-16 2014-10-28 Tohoku University Method for oxidizing alcohols
JP6049619B2 (ja) 2010-08-31 2016-12-21 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル ナノヒドロキシアパタイトを含む多孔質多糖足場、及び骨形成のための使用
EP3263102A1 (en) 2011-09-30 2018-01-03 Horizon Therapeutics, LLC Methods of therapeutic monitoring of nitrogen scavenging drugs
EP2607366A1 (en) 2011-12-21 2013-06-26 Lunamed AG Glycerol phenyl butyrate esters
ES2807951T3 (es) 2012-04-20 2021-02-24 Immedica Pharma Ab Métodos de monitorización terapéutica de profármacos de ácido fenilacético
CN104797272A (zh) 2012-11-21 2015-07-22 海波龙治疗公司 施用及评价用于治疗肝性脑病的氮清除药物的方法
CN103304402B (zh) 2013-05-24 2015-04-22 苏州诚和医药化学有限公司 一种制备4-苯-1-丁酸的方法
WO2015048818A1 (en) 2013-09-30 2015-04-02 Hyperion Therapeutics, Inc. Diagnosing, grading, monitoring, and treating hepatic encephalopathy
EP2986325B1 (en) 2013-10-14 2019-06-26 Immedica Pharma AB Methods of treating urea cycle disorders
WO2015063659A1 (en) 2013-10-30 2015-05-07 Lupin Limited Process for the preparation of glycerol phenylbutyrate
WO2015187641A1 (en) 2014-06-04 2015-12-10 Horizon Therapeutics, Inc. Methods for treating urea cycle disorders to prevent hyperammonemic crises by controlling blood ammonia levels
WO2017147193A1 (en) 2016-02-22 2017-08-31 Horizon Therapeutics, Llc Treatment of urea cycle disorders in neonates and infants
US9914692B2 (en) 2016-05-25 2018-03-13 Horizon Therapeutics, Llc Procedure for the preparation of 4-phenyl butyrate and uses thereof
US20190076383A1 (en) 2017-09-08 2019-03-14 Horizon Therapeutics, Llc Methods for treating urea cycle disorders
US10668040B2 (en) 2017-09-11 2020-06-02 Horizon Therapeutics, Llc Treatment of urea cycle disorders in neonates and infants

Also Published As

Publication number Publication date
TW201741278A (zh) 2017-12-01
WO2017205515A1 (en) 2017-11-30
US20170362160A1 (en) 2017-12-21
US10329236B2 (en) 2019-06-25
US20170342018A1 (en) 2017-11-30
US9914692B2 (en) 2018-03-13
US20200002266A1 (en) 2020-01-02
US11014870B2 (en) 2021-05-25

Similar Documents

Publication Publication Date Title
AR109248A1 (es) Procedimiento para la preparación de 4-fenilbutirato y sus usos
CL2020002805A1 (es) Método para identificar un modulador de un sistema biológico; método para identificar un modulador de un proceso de enfermedad (divisional 201302526)
CO2018010877A2 (es) Ácido acrílico y métodos de producción del mismo
AR103930A1 (es) Proceso para preparar mesotriona
UY37428A (es) Modulador del regulador de conductancia de transmembrana de fibrosis quística, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador
AR098798A1 (es) Procedimiento para la diazotización de 2,5-dicloroanilinas
EA201990415A1 (ru) Плавучий модуль для модульных платформ солнечных панелей
CU24579B1 (es) Proceso de preparación de una vacuna tetravalente atenuada contra el virus del dengue
CO6590210A1 (es) Complejo obtenido a partir de mezclas de ácido hialurónico o una sal del mismo y sulfato de condroitina
AR107494A1 (es) Proceso para la preparación de osimertinib (azd9291) o una sal del mismo, y “azd9291 anilina” o una sal de la misma
BR112015029714A2 (pt) processo para preparar derivados de 4,6-bis(ariloxi)pirimidina
CL2016002864A1 (es) Método para modificar madera
CL2011002069A1 (es) Metodo para modificar carbohidrato que comprende formar una mezcla del carbohidrato con un solvente y la reaccion del carbohidrato con radicales hidroxilo que son generados por fotolisis de peroxido en solucion acuoso, con una relacion de luz uv a peroxido de 20-500 watts/g.
AR097596A1 (es) Proceso para preparar celulosa
CO6511211A2 (es) Composiciones estable de sns 595 y métodos de preparación
PE20121473A1 (es) Uso de 4-[etil(dimetil)amonio]butanoato en el tratamiento de enfermedades cardiovasculares
UY35124A (es) Método para la producción de ácido peracético en equilibrio, y ácido peracético en equilibrio que se puede obtener con dicho método
AR099070A1 (es) Ácido (s)- 3-metil-abscísico y ésteres del mismo
AR095548A1 (es) Preparación de ácido 4-amino-2,4-dioxobutanoico
CL2018000202A1 (es) Método e instalación para una síntesis química
AR098023A1 (es) Un proceso para preparar isoxaflutol
AR119664A1 (es) Proceso de conversión de sulfato de potasio a hidrogenosulfato de potasio
PL414162A1 (pl) Sposób utleniania limonenu na węglach aktywnych
AR117098A1 (es) Proceso para la preparación de 2,6-diclorobenzonitrilo
BR112016015411A2 (pt) Processo para fazer etanolaminas

Legal Events

Date Code Title Description
FB Suspension of granting procedure